Skip to main content

Table 2 single factor and multi factor analysis

From: Development and validation of a competitive risk model in patients with rectal cancer: based on SEER database

Factors

Define

Univariate analysis

Multivariate analysis

HR (95%CI)

Z (P)

HR (95%CI)

Z (P)

Age

 

1.014 (1.011–1.016)

11.255 (< 0.001)

1.016 (1.013–1.019)

10.966 (0)

Marriage

Married

Ref.

   

Single

1.354 (1.254–1.462)

7.723 (< 0.001)

1.233 (1.133–1.341)

4.854 (0)

Widowed

1.576 (1.443–1.721)

10.146 (< 0.001)

1.317 (1.188–1.461)

5.236 (0)

Other

1.275 (1.167–1.392)

5.384 (< 0.001)

1.174 (1.064–1.297)

3.178 (0.002)

Race

White

Ref.

   

Black

1.341 (1.220–1.474)

6.084 (< 0.001)

1.205 (1.086–1.336)

3.532 (0)

Other

1.026 (0.931–1.130)

0.512 ( > 0.05)

1.114 (1.009–1.23)

2.145 (0.032)

Sex

Female

Ref.

   

Male

1.105 (1.041–1.173)

3.300 (< 0.001)

1.161 (1.085–1.241)

4.355 (0)

Deposits

Yes

Ref.

   

No

0.371 (0.335–0.410)

 − 19.456 (< 0.001)

0.585 (0.526–0.651)

− 9.814 (0)

Others

1.062 (0.958–1.178)

1.150 ( > 0.05)

0.802 (0.706–0.912)

− 3.359 (0.001)

Behav

Behav1

Ref.

   

Behav2

0.508 (0.445–0.580)

 − 9.973 (P < 0.001)

0.856 (0.745–0.984)

− 2.191 (0.028)

Behav3

0.495 (0.437–0.561)

 − 11.061 (P < 0.001)

0.91 (0.796–1.039)

− 1.392 (0.16)

Other

1.223 (1.119–1.336)

4.459 (P < 0.001)

1.059 (0.952–1.177)

1.052(0.29)

Grade

I

Ref.

   

II

1.420 (1.257–1.604)

5.630 (P < 0.001)

1.214 (1.069–1.379)

2.991 (0.003)

III, IV

2.615 (2.288–2.990)

14.070 (P < 0.001)

1.641 (1.419–1.898)

6.682 (0)

AJCC Stage

I

Ref.

   

II

2.123 (1.914–2.354)

14.258 (P < 0.001)

1.69 (1.437–1.988)

6.332 (0)

III

2.840 (2.583–3.122)

21.607 (P < 0.001)

1.735 (1.479–2.035)

6.766 (0)

IV

11.515 (10.421–12.723)

47.997 (P < 0.001)

3.658 (2.968–4.507)

12.169 (0)

T

T1

Ref.

   

T2

0.926 (0.817–1.050)

 − 1.110 (P > 0.05)

0.931 (0.814–1.066)

− 1.037 (0.3)

T3

2.046 (1.864–2.246)

15.069 (P < 0.001)

1.138 (0.994–1.303)

1.867 (0.062)

T4

4.487 (4.019–5.011)

26.678 (P < 0.001)

1.764 (1.512–2.059)

7.201 (0)

N

N0/N1

Ref.

   

N2

2.336 ( 2.173–2.510)

23.080 (P < 0.001)

1.261 (1.153–1.379)

5.073 (0)

Surgery

1

Ref.

   

2

0.263 (0.246–0.281)

 − 38.849 (P < 0.001)

0.47 (0.405–0.546)

− 9.918 (0)

LNSur

No

Ref.

   

Yes

0.584 (0.550–0.621)

 − 17.110 (P < 0.001)

1.074 (0.884–1.304)

0.72 (0.47)

Unknown

0.770 (0.588–1.010)

 − 1.884 (P > 0.05)

1.055 (0.766–1.453)

0.326 (0.74)

Radiation

Yes

Ref.

   
 

No

1.001 (0.944–1.062)

0.050 (P > 0.05)

-

 

Chemotherapy

Yes

Ref.

   

No

0.727 (0.682–0.776)

 − 9.649 (P < 0.001)

1.392 (1.273–1.521)

7.265 (0)

CEA

Yes

Ref.

   

No

0.422 (0.392–0.454)

 − 23.330 (P < 0.001)

0.724 (0.668–0.784)

− 7.934 (0)

Others

0.538 (0.503– 0.576)

 − 18.013 (P < 0.001)

0.858 (0.794–0.927)

− 3.881 (0)

Brain

No

Ref.

   

Yes

8.645 (5.075–14.726)

7.937 (P < 0.001)

2.613 (1.727–3.955)

4.545 (0)

Positive

No

Ref.

   

Yes

2.748 (2.560–2.950)

28.004 (P < 0.001)

1.685 (1.53–1.856)

10.603 (0)

Other

2.622 (2.437–2.820)

25.901 (P < 0.001)

1.239 (1.025–1.496)

2.221 (0.026)

Liver

No

Ref.

   

Yes

5.424 (5.044–5.833)

45.580 (P < 0.001)

1.405 (1.215–1.624)

4.593 (0)

Lung

No

Ref.

   

Yes

5.795 (5.253–6.392)

35.117 (P < 0.001)

1.294 (1.121–1.494)

3.511 (0)

Bone

No

Ref.

   

Yes

9.253 (7.282–11.757)

19.049 (P < 0.001)

1.712 (1.314–2.232)

3.977 (0)

Size

< 3 cm

Ref.

   

3–5 cm

1.680 (1.546–1.826)

12.242 (P < 0.001)

1.089 (0.993–1.196)

1.803 (0.071)

5–cm

2.579 (2.387–2.786)

24.014 (P < 0.001)

1.256 (1.145–1.378)

4.845 (0)

Malignant

1

Ref.

   

2

1.057 (0.983–1.136)

1.498 (P > 0.05)

1.053 (0.97–1.142)

1.226 (0.22)

3–

1.211 (1.078–1.359)

3.233 (P < 0.05)

1.225 (1.076–1.395)

3.074 (0.002)

  1. HR, Hazard radio; CI, Confidence interval; Deposits, tumor deposits; Behav, pathological type; Grade, differentiation grade; AJCC, American Joint Committee on Cancer; LNSur, regional lymph node surgery information; CEA, carcinoembryonic antigen; Brain, brain metastasis; Positive, positive lymph nodes; Liver, metastasis; Lung, Lung metastasis; Bone, bone metastasis; Malignant, malignant number tumors